|
1
|
Chen ST, Choo KB, Hou MF, Yeh KT, Kuo SJ
and Chang JG: Deregulated expression of the PER1, PER2 and PER3
genes in breast cancers. Carcinogenesis. 26:1241–1246. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Oster H, Werner C, Magnone MC, Mayser H,
Feil R, Seeliger MW, Hofmann F and Albrecht U: cGMP-dependent
protein kinase II modulates mPer1 and mPer2 gene induction and
influences phase shifts of the circadian clock. Curr Biol.
13:725–733. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zieker D, Jenne I, Koenigsrainer I,
Zdichavsky M, Nieselt K, Buck K, Zieker J, Beckert S, Glatzle J,
Spanagel R, et al: Circadian expression of clock- and tumor
suppressor genes in human oral mucosa. Cell Physiol Biochem.
26:155–166. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhao N, Tang H, Yang K and Chen D:
Circadian rhythm characteristics of oral squamous cell carcinoma
growth in an orthotopic xenograft model. Onco Targets Ther.
6:41–46. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
King DP and Takahashi JS: Molecular
genetics of circadian rhythms in mammals. Annu Rev Neurosci.
23:713–742. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yang X, Wood PA, Oh EY, Du-Quiton J,
Ansell CM and Hrushesky WJ: Down regulation of circadian clock gene
Period 2 accelerates breast cancer growth by altering its daily
growth rhythm. Breast Cancer Res Treat. 117:423–431. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rohling JH, vanderLeest HT, Michel S,
Vansteensel MJ and Meijer JH: Phase resetting of the mammalian
circadian clock relies on a rapid shift of a small population of
pacemaker neurons. PLoS One. 6:e254372011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhanfeng N, Yanhui L, Zhou F, Shaocai H,
Guangxing L and Hechun X: Circadian genes Per1 and Per2 increase
radiosensitivity of glioma in vivo. Oncotarget. 6:9951–9958. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhao N, Yang K, Yang G, Chen D, Tang H,
Zhao D and Zhao C: Aberrant expression of clock gene period1 and
its correlations with the growth, proliferation and metastasis of
buccal squamous cell carcinoma. PLoS One. 8:e558942013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ye H, Yang K, Tan XM, Fu XJ and Li HX:
Daily rhythm variations of the clock gene PER1 and cancer-related
genes during various stages of carcinogenesis in a golden hamster
model of buccal mucosa carcinoma. Onco Targets Ther. 8:1419–1426.
2015.PubMed/NCBI
|
|
11
|
Zheng B, Albrecht U, Kaasik K, Sage M, Lu
W, Vaishnav S, Li Q, Sun ZS, Eichele G, Bradley A, et al:
Nonredundant roles of the mPer1 and mPer2 genes in the mammalian
circadian clock. Cell. 105:683–694. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wood PA, Yang X, Taber A, Oh EY, Ansell C,
Ayers SE, Al-Assaad Z, Carnevale K, Berger FG, Peña MM, et al:
Period 2 mutation accelerates ApcMin/+ tumorigenesis. Mol Cancer
Res. 6:1786–1793. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tan XM, Ye H, Yang K, Chen D, Wang QQ,
Tang H and Zhao NB: Circadian variations of clock gene Per2 and
cell cycle genes in different stages of carcinogenesis in golden
hamster buccal mucosa. Sci Rep. 5:99972015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hua H, Wang Y, Wan C, Liu Y, Zhu B, Yang
C, Wang X, Wang Z, Cornelissen-Guillaume G and Halberg F: Circadian
gene mPer2 overexpression induces cancer cell apoptosis. Cancer
Sci. 97:589–596. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cheng AY, Zhang Y, Mei HJ, Fang S, Ji P,
Yang J, Yu L and Guo WC: Construction of a plasmid for
overexpression of human circadian gene period2 and its biological
activity in osteosarcoma cells. Tumour Biol. 36:3735–3743. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Milagro FI, Gómez-Abellán P, Campión J,
Martínez JA, Ordovás JM and Garaulet M: CLOCK, PER2 and BMAL1 DNA
methylation: Association with obesity and metabolic syndrome
characteristics and monounsaturated fat intake. Chronobiol Int.
29:1180–1194. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang J, Morita Y, Han B, Niemann S,
Löffler B and Rudolph KL: Per2 induction limits lymphoid-biased
haematopoietic stem cells and lymphopoiesis in the context of DNA
damage and ageing. Nat Cell Biol. 18:480–490. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Christiansen SL, Bouzinova EV, Fahrenkrug
J and Wiborg O: Altered expression pattern of clock genes in a rat
model of depression. Int J Neuropsychopharmacol. 19:pyw0612016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cogliano VJ, Baan R, Straif K, Grosse Y,
Lauby-Secretan B, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L,
Guha N, Freeman C, et al: Preventable exposures associated with
human cancers. J Natl Cancer Inst. 103:1827–1839. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jung-Hynes B, Huang W, Reiter RJ and Ahmad
N: Melatonin resynchronizes dysregulated circadian rhythm circuitry
in human prostate cancer cells. J Pineal Res. 49:60–68.
2010.PubMed/NCBI
|
|
21
|
Hsu CM, Lin SF, Lu CT, Lin PM and Yang MY:
Altered expression of circadian clock genes in head and neck
squamous cell carcinoma. Tumour Biol. 33:149–155. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lengyel Z, Lovig C, Kommedal S, Keszthelyi
R, Szekeres G, Battyáni Z, Csernus V and Nagy AD: Altered
expression patterns of clock gene mRNAs and clock proteins in human
skin tumors. Tumour Biol. 34:811–819. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lin YM, Chang JH, Yeh KT, Yang MY, Liu TC,
Lin SF, Su WW and Chang JG: Disturbance of circadian gene
expression in hepatocellular carcinoma. Mol Carcinog. 47:925–933.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Soták M, Polidarová L, Ergang P, Sumová A
and Pácha J: An association between clock genes and
clock-controlled cell cycle genes in murine colorectal tumors. Int
J Cancer. 132:1032–1041. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gery S, Gombart AF, Yi WS, Koeffler C,
Hofmann WK and Koeffler HP: Transcription profiling of C/EBP
targets identifies Per2 as a gene implicated in myeloid leukemia.
Blood. 106:2827–2836. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hu ML, Yeh KT, Lin PM, Hsu CM, Hsiao HH,
Liu YC, Lin HY, Lin SF and Yang MY: Deregulated expression of
circadian clock genes in gastric cancer. BMC Gastroenterol.
14:672014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fu L, Pelicano H, Liu J, Huang P and Lee
C: The circadian gene Period2 plays an important role in tumor
suppression and DNA damage response in vivo. Cell. 111:41–50. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Štorcelová M, Vicián M, Reis R, Zeman M
and Herichová I: Expression of cell cycle regulatory factors hus1,
gadd45a, rb1, cdkn2a and mre11a correlates with expression of clock
gene per2 in human colorectal carcinoma tissue. Mol Biol Rep.
40:6351–6361. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sun CM, Huang SF, Zeng JM, Liu DB, Xiao Q,
Tian WJ, Zhu XD, Huang ZG and Feng WL: Per2 inhibits k562 leukemia
cell growth in vitro and in vivo through cell cycle arrest and
apoptosis induction. Pathol Oncol Res. 16:403–411. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang Q, Ao Y, Yang K, Tang H and Chen D:
Circadian clock gene Per2 plays an important role in cell
proliferation, apoptosis and cell cycle progression in human oral
squamous cell carcinoma. Oncol Rep. 35:3387–3394. 2016.PubMed/NCBI
|
|
31
|
Fernald K and Kurokawa M: Evading
apoptosis in cancer. Trends Cell Biol. 23:620–633. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Reynolds A, Leake D, Boese Q, Scaringe S,
Marshall WS and Khvorova A: Rational siRNA design for RNA
interference. Nat Biotechnol. 22:326–330. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chitikova Z, Pusztaszeri M, Makhlouf AM,
Berczy M, Delucinge-Vivier C, Triponez F, Meyer P, Philippe J and
Dibner C: Identification of new biomarkers for human papillary
thyroid carcinoma employing NanoString analysis. Oncotarget.
6:10978–10993. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Granda TG, Liu XH, Smaaland R, Cermakian
N, Filipski E, Sassone-Corsi P and Lévi F: Circadian regulation of
cell cycle and apoptosis proteins in mouse bone marrow and tumor.
FASEB J. 19:304–306. 2005.PubMed/NCBI
|
|
35
|
Koyanagi S, Kuramoto Y, Nakagawa H,
Aramaki H, Ohdo S, Soeda S and Shimeno H: A molecular mechanism
regulating circadian expression of vascular endothelial growth
factor in tumor cells. Cancer Res. 63:7277–7283. 2003.PubMed/NCBI
|
|
36
|
Dai Y, Xia W, Song T, Su X, Li J, Li S,
Chen Y, Wang W, Ding H, Liu X, et al: MicroRNA-200b is
overexpressed in endometrial adenocarcinomas and enhances MMP2
activity by downregulating TIMP2 in human endometrial cancer cell
line HEC-1A cells. Nucleic Acid Ther. 23:29–34. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Gotoh T, Vila-Caballer M, Santos CS, Liu
J, Yang J and Finkielstein CV: The circadian factor Period 2
modulates p53 stability and transcriptional activity in unstressed
cells. Mol Biol Cell. 25:3081–3093. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Assadian S, El-Assaad W, Wang XQ, Gannon
PO, Barrès V, Latour M, Mes-Masson AM, Saad F, Sado Y, Dostie J, et
al: p53 inhibits angiogenesis by inducing the production of
Arresten. Cancer Res. 72:1270–1279. 2012. View Article : Google Scholar : PubMed/NCBI
|
